At Keratoconus 360, Prof. Farhad Hafezi of the ELZA Institute explored the evolution of CXL, from the Dresden protocol to Individualized corneal cross-linking protocols like ELZA-sub400 and PACE.
Dr. Emilio Torres-Netto presented ELZA-PACE cross-linking at BRASCRS 2025, a customised, tissue-preserving keratoconus vision rehabilitation method with promising clinical outcomes.
At EgSCRS, ELZA’s pyramid approach to keratoconus: ELZA-sub400, PACE, ECO-CAIRS, and AI-guided diagnostics was presented in detail.
ELZA-PACE combines epi-on cross-linking with customized PTK for keratoconus without stromal tissue removal – as reported by Ocular Surgery News
During this visit to TOS 2025, Prof. Hafezi presented ECO-CAIRS and ELZA-PACE and highlighted the Light for Sight Foundation’s work to improve care for children with Down Syndrome.
At the ESCRS Winter Meeting 2025, Prof. Farhad Hafezi and Dr. Emilio Torres-Netto presented research on corneal cross-linking (CXL), including high-fluence protocols, keratoconus management, and biomechanical assessments.
Our latest review on corneal cross-linking (CXL), published in Progress in Retinal and Eye Research, explores its evolution, advanced protocols like ELZA-PACE, and clinical applications.
Exploring comprehensive keratoconus treatment, from cross-linking to surgery, in the highly respected scientific journal Nature Reviews.
Prof. Hafezi presents Femto-CAIRS and high fluence cross-linking, highlighting its advantages for keratoconus treatment and improving visual outcomes
The AAO-ESCRS Joint Symposium, convened leading ophthalmology experts to explore the latest developments in CXL.